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A B S T R A C T
Background: The World Health Organization (WHO) and the International Labour Organization (ILO) are developing a joint methodology for estimating the national
and global work-related burden of disease and injury (WHO/ILO joint methodology), with contributions from a large network of experts. In this paper, we present the
protocol for two systematic reviews of parameters for estimating the number of deaths and disability-adjusted life years from melanoma and non-melanoma skin
cancer (or keratinocyte carcinoma) from occupational exposure to solar ultraviolet radiation, to inform the development of the WHO/ILO joint methodology.
Objectives: We aim to systematically review studies on occupational exposure to solar ultraviolet radiation (Systematic Review 1) and systematically review and meta-
analyse estimates of the effect of occupational exposure to solar ultraviolet radiation on melanoma and non-melanoma skin cancer (Systematic Review 2), applying the
Navigation Guide systematic review methodology as an organizing framework and conducting both systematic reviews in tandem and in a harmonized way.
Data sources: Separately for Systematic Reviews 1 and 2, we will search electronic academic databases for potentially relevant records from published and un-
published studies, including Ovid Medline, PubMed, EMBASE, and Web of Science. We will also search electronic grey literature databases, Internet search engines
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and organizational websites; hand-search reference list of previous systematic reviews and included study records and consult additional experts.
Study eligibility and criteria: We will include working-age (≥15 years) workers in the formal and informal economy in any WHO and/or ILO Member State, but
exclude children (< 15 years) and unpaid domestic workers. For Systematic Review 1, we will include quantitative studies on the prevalence of relevant levels of
occupational exposure to solar ultraviolet radiation (i.e.< 0.33 SED/d and≥0.33 SED/d) and of the total working time spent outdoors, stratified by country, sex, age
and industrial sector or occupation, in the years 1960 to 2018. For Systematic Review 2, we will include randomized controlled trials, cohort studies, case-control
studies and other non-randomized intervention studies with an estimate of the effect of any occupational exposure to solar ultraviolet radiation (i.e., ≥0.33 SED/d)
on the prevalence of, incidence of or mortality due to melanoma and non-melanoma skin cancer, compared with the theoretical minimum risk exposure level
(i.e.< 0.33 SED/d).
Study appraisal and synthesis methods: At least two review authors will independently screen titles and abstracts against the eligibility criteria at a first stage and full
texts of potentially eligible records at a second stage, followed by extraction of data from qualifying studies. At least two review authors will assess the risk of bias and
the quality of evidence, using the most suited tools currently available. For Systematic Review 2, if feasible, we will combine relative risks using meta-analysis. We
will report results using the guidelines for accurate and transparent health estimates reporting (GATHER) for Systematic Review 1 and the preferred reporting items
for systematic reviews and meta-analyses guidelines (PRISMA) for Systematic Review 2.
PROSPERO registration number: CRD42018094817.
1. Background
The World Health Organization (WHO) and the International
Labour Organization (ILO) are developing a joint methodology for es-
timating the work-related burden of disease and injury (WHO/ILO joint
methodology) (Ryder, 2017). The organizations plan to estimate the
numbers of deaths and disability-adjusted life years (DALYs) that are
attributable to selected occupational risk factors for the year 2015. The
WHO/ILO joint methodology will be based on already existing WHO
and ILO methodologies for estimating the burden of disease for selected
occupational risk factors (International Labour Organization, 2014;
Prüss-Üstün et al., 2017). It will expand existing methodologies with
estimation of the burden of several prioritized additional pairs of oc-
cupational risk factors and health outcomes. For this purpose, popula-
tion attributable fractions (Murray et al., 2004) – the proportional re-
duction in burden from the health outcome achieved by a reduction of
exposure to the risk factor to zero – will be calculated for each addi-
tional risk factor-outcome pair, and these fractions will be applied to
the total disease burden envelopes for the health outcome from the
WHO Global Health Estimates (World Health Organization, 2017).
The WHO/ILO joint methodology will include a methodology for
estimating the burden of melanoma and non-melanoma skin cancer
(NMSC) (also known as keratinocyte carcinoma) from occupational
exposure to solar ultraviolet (UV) radiation (UVR) if feasible, as one
additional prioritized risk factor-outcome pair. To optimize parameters
used in estimation models, a systematic review is required of studies on
the prevalence of occupational exposure to the risk factor (‘Systematic
Review 1’), as well as a second systematic review and meta-analysis of
studies with estimates of the effect of occupational exposure to solar
UVR on melanoma and NMSC (‘Systematic Review 2’). The term ‘effect’
is used throughout this protocol to include both association and causal
effect. In the current paper, we present the protocol for these two sys-
tematic reviews, in parallel to presenting systematic review protocols
on other additional risk factor-outcome pairs elsewhere (Descatha et al.,
2018; Godderis et al., 2018; Hulshof et al., 2018; Li et al., 2018;
Mandrioli et al., 2018; Rugulies et al., 2018; Teixeira et al., 2018;
Tenkate et al., 2018). To our knowledge, this is the first systematic
review protocol of its kind. The WHO/ILO joint estimation metho-
dology and the burden of disease estimates are separate from these
systematic reviews, and they will be described and reported elsewhere.
We refer separately to Systematic Reviews 1 and 2, because the two
systematic reviews address different objectives and therefore require
different methodologies. The two systematic reviews will, however, be
harmonized and conducted in tandem. This will ensure that – in the
later development of the methodology for estimating the burden of
disease from this risk factor–outcome pair – the parameters on the risk
factor prevalence are optimally matched with the parameters from
studies on the effect of the risk factor on the designated outcome. The
findings from Systematic Reviews 1 and 2 will be reported in two dis-
tinct journal articles. For this protocol and the second one in the series
with occupational exposure to solar UVR as the risk factor (Tenkate
et al., 2018), the Systematic Review 1 of the two different protocols will
be performed jointly.
1.1. Rationale
To consider the feasibility of estimating the burden of melanoma
and NMSC from occupational exposure to solar UVR, and to ensure that
potential estimates of burden of disease are reported in adherence with
the guidelines for accurate and transparent health estimates reporting
(GATHER) (Stevens et al., 2016), WHO and ILO require a systematic
review of studies on the prevalence of relevant levels of occupational
exposure to solar UVR (Systematic Review 1), as well as a second sys-
tematic review and meta-analysis of studies with estimates of the re-
lative effect of occupational exposure to solar UVR on melanoma and
NMSC prevalence, incidence or mortality, compared with the theore-
tical minimum risk exposure level (Systematic Review 2). The theore-
tical minimum risk exposure level is the exposure level that would re-
sult in the lowest possible population risk, even if it is not feasible to
attain this exposure level in practice (Murray et al., 2004). These data
and effect estimates should be tailored to serve as parameters for esti-
mating the burden of melanoma and NMSC from occupational exposure
to solar UVR in the WHO/ILO joint methodology.
Different contexts may result in different exposures and effects of
these exposures on the health outcome. Work in the informal economy,
for example, may lead to different exposures and exposure effects than
does work in the formal economy. The informal economy is defined as
“all economic activities by workers and economic units that are – in law
or in practice – not covered or insufficiently covered by formal ar-
rangements”, but excluding “illicit activities, in particular the provision
of services or the production, sale, possession or use of goods forbidden
by law, including the illicit production and trafficking of drugs, the il-
licit manufacturing of and trafficking in firearms, trafficking in persons,
and money laundering, as defined in the relevant international treaties”
(p. 4) (International Labour Conference, 2015). Therefore, we will
consider the formality of the economy studied in included studies in
both systematic reviews.
1.1.1. Non-melanoma skin cancer
Globally, NMSC are the most common cancers in fair-skinned po-
pulations (Pelucchi et al., 2007). Solar UVR is the main cause of NMSC
in fair-skinned people, responsible for an estimated 50–70% of squa-
mous cell carcinoma (SCC) and 50–90% of basal cell carcinoma (BCC)
(D'Orazio et al., 2013). Recent systematic review and meta-analytic
evidence found that the risk among outdoor workers was raised for SCC
and actinic keratoses by 77%, and for BCC by 43% respectively, com-
pared with the general population (Bauer et al., 2011; Schmitt et al.,
2011).
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1.1.2. Cutaneous melanoma
Evidence on the effect on incident melanoma among outdoor
workers has been described as unclear, with some studies reporting an
inverse association with continuous UVR exposure in adult age (e.g.
outdoor professions) as opposed to intermittent exposure (e.g. leisure
time or childhood exposure) (Armstrong and Cust, 2017). We are not
aware of a previous systematic review of the effect of occupational
exposure to solar UVR on melanoma skin cancers. In IARC Monograph
100D (International Agency for Research on Cancer, 2012) the “ob-
jective cutaneous signs of skin damage” showed an “almost uniformly,
strong positive association with melanoma”, suggesting a possible in-
consistency with the lack of evidence for a raised melanoma incidence
in outdoor workers. Appendix A presents additional background in-
formation on occupational solar UVR exposure and both melanoma and
NMSCs.
1.2. Description of the risk factor
The definition of the risk factor, the risk factor levels and the the-
oretical minimum risk exposure level are presented in Table 1, and they
are explained below in more detail. Since the theoretical minimum risk
exposure level is usually set empirically based on the causal epide-
miological evidence, we will change the assumed level as evidence
suggests. If several studies report exposure levels differing from the
standard levels we define here, then, if possible, we will convert the
reported levels to the standard levels and, if not possible, we will report
analyses on these alternate exposure levels as supplementary informa-
tion in the systematic reviews. In the latter case, our protocol will be
updated to reflect our new analyses.
1.2.1. Risk factor definition
UVR, part of the spectrum of electromagnetic radiation emitted by
the sun, is divided into three bands of different wavelengths: UVA
400–315 nm; (ii) UVB 315–280 nm; and (iii) UVC 280–100 nm (Lucas
et al., 2006). However, the exact wavelengths at which divisions are
constructed differ accross disciplines.
Artificial sources of UVR (e.g. lamps and welding) can include all
UV bands (UVA, UVB and UVC), whereas terrestrial solar UVR only
contains UVA and UVB bands. UVR in band C (280–100 nm) is totally
filtered by the ozone layer, which also absorbs the majority (~90%) of
UVB, while UVA passes through the atmosphere with little change.
While all three types of UVR have differing effects on humans, UVA and
UVB are primarily responsible for skin malignancies. UVR in band A
(400–315 nm) has the longest wavelength and penetrates the skin more
deeply, reaching the dermis and generating reactive oxygen species
capable of damaging deoxyribonucleic acid (DNA). On the contrary,
UVB is almost completely absorbed by DNA in the epidermis. While
UVA penetrates the human skin more deeply than UVB, action spectra
for biological responses indicate that it is radiation in the UVB range
that is absorbed by DNA – subsequent damage to DNA appears to be a
key factor in the initiation of the carcinogenic process in skin (Lucas
et al., 2006). More information about the environmental and individual
factors influencing solar UVR exposure and effects in human skin, in-
cluding immunosuppression by UVR, can be found in Appendix A.
1.2.2. Risk factor levels
For solar UV exposure to the skin, the ‘radiant exposure’ (or dose) is
commonly described in terms of a biological weighting for erythema
(i.e. skin reddening), and can be expressed in two ways: (1) Minimal
Erythemal Dose (MED), which provides the dose of UVR (particularly
UVB) required to cause a minimal erythematous skin response within
24 h after exposure, with specific skin type (e.g. fair, dark) altering the
response time (and dose required to produce one MED), which varies
according to the Fitzpatrick scale (D'Orazio et al., 2013); or (2) Stan-
dard Erythema Dose (SED) which is more of a ‘standardized dose’,
where 1 SED equals 100 Jm−2 of erythemally weighted UV irradiance
(Diffey, 2002).
For occupational exposure the most widely used UV exposure limit
was initially developed by the American Conference of Governmental
Industrial Hygienists (ACGIH) and has been adopted internationally by
the International Commission on Non-Ionizing Radiation Protection
(ICNIRP) (International Commission on Non-Ionizing Radiation
Protection, 2012). This standard limit is based on threshold data (i.e.
the minimum exposure needed to produce a specific biological effect)
for erythema and photokeratitis, which are both acute effects. It de-
scribes ‘allowed’ daily (i.e. 8 h) exposure at each wavelength in the UV
spectrum (i.e. the so-called ‘UV Hazard Curve’), with the lowest (or
limiting) dose being 30 Jm−2 at 270 nm. This is equivalent to ap-
proximately 1.0 to 1.33 SED per day in case of the solar spectrum. This
is approximately one half of an MED for a fair skinned person (2.0 SED,
skin type I and II) (Diffey, 2002). In our systematic reviews, we will use
SED as the metric for exposure to UVR.
1.2.3. Theoretical minimum risk exposure level
Because of the ubiquitous nature of solar UVR, it is one of the few
occupational exposures that everyone is exposed to, whether an out-
door worker or not. Fortunately, ongoing, regular exposure at or below
the ACGIH/ICNIRP exposure standard/guideline for UVR is considered
to produce an extremely small risk for the development of skin cancers.
However, with this guideline representing a dose of 1.0 to 1.3 SED/day,
it likely includes solar UV exposure of indoor workers, considering that
the annual ‘leisure’ UV dose for, for example, the German population is
currently considered to be 0.33 SED/day (Knuschke et al., 2004;
Wittlich et al., 2016). Further, it has been calculated that the "tolerable"
risk for SCC corresponds to 1.15 SED/day, with the "acceptable" risk at
0.115 SED/day (German Society of Occupational and Environmental
Table 1
Definitions of the risk factor, risk factor levels and the minimum risk exposure level.
Concept Definition
Risk factor Occupational exposure to solar UVR, defined as UVA and UVB from solar radiation reaching the worker's skin.
Risk factor levels The occupational exposure limit for artificial UVR is recognized as being 30 Jm−2 (effectively weighted irradiance) according to
ICNIRP and the European directive 2006/25/EC as a daily 8-hour value. This equates to a skin exposure of 1.0 and 1.33 Standard
Erythemal Dose (SED; 1 SED=100 Jm−2 of erythemally weighted irradiance) in the solar spectrum. ‘Leisure’ (i.e. non-occupational)
exposure is considered to be roughly 1/3 of this.
Two risk factor levels will be used:
1. Non-exposed (i.e. non-occupational exposure < 0.33 SED/day).
2. Exposed (occupational exposure ≥0.33 SED/day).
If sufficient data are available, then additional risk factor levels will be constructed as multiples of the theoretical minimum risk
exposure level (i.e. 0.33 SED/day).
If quantitative estimates of solar UVR are unavailable, then workers will be categorized into dichotomous variables “no occupational
exposure to solar UVR” (i.e. unexposed) and “exposed to any occupational solar UVR” (i.e. exposed).
Theoretical minimum risk exposure level A daily solar UVR exposure of < 0.33 SED/day (50° N/S), adjusted for latitude of the outdoor worker.
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Medicine, 2017). Personal UV dosimetric measurements conducted
with outdoor workers have shown a consistent trend for exposures to
exceed the ACGIH/ICNIRP standard, often by many times (Gies et al.,
2009; Hammond et al., 2009; Siani et al., 2011), with exposures of up to
5 SED/day common in German outdoor workers (Wittlich, 2017;
Wittlich et al., 2016).
Overall, as we consider the theoretical minimum risk exposure level
to represent no occupational exposure to solar UVR, for the purpose of
this review we will use the value of 0.33 SED/day as the minimum risk
exposure level, as this represents the recognized ‘leisure’ exposure to
solar UV for the German population, and because ‘adjustment’ factors
are available to account for latitude (Wittlich et al., 2016), therefore
enabling baseline/comparator geographic exposure estimates.
1.3. Description of the outcome
The WHO Global Health Estimates group health outcomes into stan-
dard burden of disease categories (World Health Organization, 2017),
based on the standard codes from the International Statistical Classifi-
cation of Diseases and Related Health Problems 10th Revision (ICD-10)
(World Health Organization, 2015). The two relevant WHO Global
Health Estimates categories for this systematic review are “II.A.8a Ma-
lignant skin melanoma” (ICD-10 code: C43) and “II.A.8b Non-melanoma
skin cancer” (C44) (World Health Organization, 2017). In line with the
WHO Global Health Estimates, we define the health outcomes covered in
Systematic Review 2 as melanoma and NMSC, defined as conditions
with ICD-10 codes C43 and C44, respectively. Because the standard
WHO burden of disease categories exclude actinic keratosis (i.e. in situ
SCC or intraepidermal neoplasm), the systematic review will also ex-
clude it. We will consider prevalence of, incidence of and mortality
from melanoma and NMSC. This review covers all the relevant WHO
Global Health Estimates categories.
1.4. How the risk factor may impact the outcome
Fig. 1 presents the logic model for our systematic review of the
assumed causal relationship between occupational exposure to solar
UVR and melanoma and NMSC. This logic model is an a priori, process-
orientated one (Rehfuess et al., 2017) that seeks to capture the com-
plexity of the risk factor-outcome causal relationship (Anderson et al.,
2011).
Mechanistic or experimental evidence suggests that occupational
exposure to solar UVR impacts melanoma and NMSC through direct
(UVB) or indirect (UVA) DNA damage (e.g. photo-dimerization).
Animal studies support a causal effect of the exposure to UVR on
melanoma and NMSC (Appendix A).
2. Objectives
1. Systematic Review 1: To systematically review quantitative studies
of any design on the prevalence of relevant levels of occupational
exposure to solar UVR (i.e. ≥0.33 SED/day and<0.33 SED/day) in
the years 1960 to 2018 among working-age workers, disaggregated
by country, sex, age (and, if possible, skin type) and industrial sector
or occupation.
2. Systematic Review 2: To systematically review and meta-analyse
randomized controlled trials, cohort studies, case-control studies
and other non-randomized intervention studies including estimates
of the relative effect of occupational exposure to solar UVR
(≥0.33 SED/day) on melanoma and NMSC in any year among
 
Mediators 
Pathway 1: Indoor vs outdoor 
worker, Job tasks with/without 
personal protections and 
Duration (continuous or 
intermittent) of outdoor work 
Pathway 2: Type of exposure 
(continuous vs intermittent) 
and personal protections used 
during leisure time 
Outcomes 
Melanoma and non 




tobacco use, phototype 
and other occupational 
risk factors (e.g. 








and formality of 
economy 
Risk factor 
Occupational exposure to 
solar UV radiation 
Context 
Governance, policy, and cultural and societal norms and values 
Globalization and the changing world of work 
Latitude / seasonality 
Fig. 1. Logic model of the causal relationship between occupational exposure to solar UVR and melanoma and NMSC.
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working-age workers, compared with the minimum risk exposure
level of< 0.33 SED/day.
3. Methods
We will apply the Navigation Guide (Woodruff and Sutton, 2014)
methodology for systematic reviews in environmental and occupational
health as our guiding methodological framework, wherever feasible.
The guide applies established systematic review methods from clinical
medicine, including standard Cochrane Collaboration methods for
systematic reviews of interventions, to the field of environmental and
occupational health to ensure systematic and rigorous evidence synth-
esis on environmental and occupational risk factors that reduces bias
and maximizes transparency (Woodruff and Sutton, 2014). The need for
further methodological development and refinement of the relatively
novel Navigation Guide has been acknowledged (Woodruff and Sutton,
2014).
Systematic Review 1 may not map well to the Navigation Guide
framework (Fig. 1 on page 1009 in Lam et al., 2016), which is tailored
to hazard identification and risk assessment. Nevertheless, steps 1–6 for
the stream on human data can be applied to systematically review ex-
posure to risk factors. Systematic Review 2 maps more closely to the
Navigation Guide framework, and we will conduct steps 1–6 for the
stream on human data, but not conduct any steps for the stream on non-
human data, although we will briefly summarize narratively the evi-
dence from non-human data that we are aware of.
We have registered the protocol in PROSPERO under
CRD42018094817. This protocol adheres with the preferred reporting
items for systematic review and meta-analysis protocols statement
(PRISMA-P) (Moher et al., 2015; Shamseer et al., 2015), with the ab-
stract adhering with the reporting items for systematic reviews in
journal and conference abstracts (PRISMA-A) (Beller et al., 2013). Any
modification of the methods stated in the present protocol will be re-
gistered in PROSPERO and reported in the systematic review itself.
Systematic Review 1 will be reported according to the GATHER
guidelines (Stevens et al., 2016), and Systematic Review 2 will be re-
ported according to the preferred reporting items for systematic review
and meta-analysis statement (PRISMA) (Liberati et al., 2009). Our re-
porting of the parameters for estimating the burden of melanoma and
NMSC from occupational exposure to solar UVR in the systematic re-
views will adhere with the requirements of the GATHER guidelines
(Stevens et al., 2016), because the WHO/ILO burden of disease esti-
mates that may be produced consecutive to the systematic reviews must
also adhere to these reporting guidelines.
3.1. Systematic Review 1
3.1.1. Eligibility criteria
The population, exposure, comparator and outcome (PECO) criteria
(Woodruff and Sutton, 2014) are described below.
3.1.1.1. Types of populations. We will include studies of working-age
(≥15 years) workers in the formal and informal economy. Studies of
children (aged< 15 years) and unpaid domestic workers will be
excluded. Participants residing in any WHO and/or ILO Member State
and any industrial setting or occupation will be included. Appendix B
provides a complete, but briefer overview of the PECO criteria.
3.1.1.2. Types of exposures. We will include studies that define
occupational exposure to solar UVR in accordance with our standard
definition (Table 1). Cumulative exposure may be the most relevant
exposure metric in theory, but we will here prioritize a non-cumulative
exposure metric because we do not have global exposure data on agreed
cumulative exposure measures. We will include all studies where
occupational exposure is measured, whether objectively (e.g. by
means of dosimeters), or subjectively, including studies that used
measurements by experts (e.g. scientists with subject matter
expertise) and self-reports by the worker or workplace administrator
or manager. If a study presents both objective and subjective
measurements, then we will prioritize objective measurements. We
will include studies with measures from any data source, including
registry data.
We will include studies on the prevalence of occupational exposure
to the risk factor, if it is disaggregated by country (defined as a WHO or
ILO Member State), sex (two categories: female, male), age (ideally in
5-year age bands, such as 20–24 years) (and, if possible, also skin type
[e.g. Fitzpatrick scale or colour]) and industrial sector (e.g.,
International Standard Industrial Classification of All Economic Activities,
Revision 4 [ISIC Rev. 4]) (United Nations, 2008) or occupation (as de-
fined, for example, by the International Standard Classification of Occu-
pations 2008 [ISCO-08]) (International Labour Office, 2012). Criteria
may be revised in order to identify optimal data disaggregation to en-
able subsequent estimation of the burden of disease.
We shall include studies with exposure prevalence data from 1960
until 31 July 2018. For optimal modelling of exposure, WHO and ILO
require exposure data up to 2018, because recent data points help
better estimate time trends, especially where data points may be sparse.
The additional rationale for this data collection window is that the
WHO and ILO aim to estimate burden of disease in the year 2015, and
we believe that the lag time from exposure to outcome will not exceed
55 years; so in their models, the organizations can use the exposure data
from as early as 1960 to determine the burden of melanoma and non-
melanoma skin cancer 55 years later in 2015. To make a conclusive
judgment on the best lag time to apply in the model, we will summarize
the existing body of evidence on the lag time between exposure to solar
UVR and melanoma and NMSC in the review. The exposure parameter
should match the one used in Systematic Review 2 or can be converted
to match it.
3.1.1.3. Types of comparators. There will be no comparator, because we
will review risk factor prevalence only.
3.1.1.4. Types of outcomes. Occupational exposure to solar UVR.
3.1.1.5. Types of studies. This Systematic Review will include
quantitative studies of any design, including cross-sectional studies.
These studies must be representative of the relevant industrial sector,
relevant occupational group or the national population. We will
exclude qualitative, modelling and case studies, as well as non-
original studies without quantitative data (e.g. letters, commentaries
and perspectives).
Study records written in any language will be included. If a study
record is written in a language other than those spoken by the authors
of this review or those of other reviews (Descatha et al., 2018; Godderis
et al., 2018; Hulshof et al., 2018; Li et al., 2018; Mandrioli et al., 2018;
Rugulies et al., 2018; Teixeira et al., 2018; Tenkate et al., 2018) in the
series (i.e. Arabic, Bulgarian, Chinese, Danish, Dutch, English, French,
Finnish, German, Hungarian, Italian, Japanese, Norwegian, Portuguese,
Russian, Spanish, Swedish and Thai), it will be translated into English.
Published and unpublished studies will be included.
Studies conducted using unethical practices will be excluded from
the review.
3.1.1.6. Types of effect measures. We will include studies with a
measure of the prevalence of occupational exposure to solar UVR.
3.1.2. Information sources and search
3.1.2.1. Electronic academic databases. We (AM and MSP) will at a
minimum search the following four electronic academic databases:
1. Ovid MEDLINE with Daily Update (1 January 1960 to 31 July
2018).
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2. PubMed (1 January 1960 to 31 July 2018).
3. EMBASE (1 January 1960 to 31 July 2018).
4. Web of Science (1 January 1960 to 31 July 2018) with inclusion of 3
databases: Science Citation Index Expanded; Social Sciences Citation
Index; and Arts and Humanities Citation Index.
The Ovid Medline search strategy for Systematic Review 1 is pre-
sented in Appendix C. We have tested and validated the search strategy
for the four selected databases. The CISDOC and TOXNET databases
were also tested, but their scopes were found to not sufficiently cover
that of the systematic review. We will perform searches in electronic
databases operated in the English language using a search strategy in
the English language. Consequently, study records that do not report
essential information (i.e. title and abstract) in English will not be
captured. We will adapt the search syntax to suit the other electronic
academic and grey literature databases. When we are nearing com-
pletion of the review, we will search the PubMed database for the most
recent publications (e.g., e-publications ahead of print) over the last six
months. Any deviation from the proposed search strategy in the actual
search strategy will be documented.
3.1.2.2. Electronic grey literature databases. We (AM and MSP) will at a
minimum search the following two electronic academic databases:
1. OpenGrey (http://www.opengrey.eu/).
2. Grey Literature Report (http://greylit.org/).
3.1.2.3. Internet search engines. We (AM and MSP) will also search the
Google (www.google.com/) and GoogleScholar (www.google.com/
scholar/) Internet search engines and screen the first 100 hits for
potentially relevant records.
3.1.2.4. Organizational websites. The websites of the seven following
international organizations and national government departments will
be searched by AM and MSP:
1. International Labour Organization (www.ilo.org/).
2. World Health Organization (www.who.int).
3. European Agency for Safety and Health at Work (https://osha.
europa.eu/en).
4. Eurostat (www.ec.europa.eu/eurostat/web/main/home).
5. China National Knowledge Infrastructure (http://www.cnki.net/).
6. Finnish Institute of Occupational Health (https://www.ttl.fi/en/).
7. National Institute of Occupational Safety and Health (NIOSH) of the
United States of America, using the NIOSH data and statistics
gateway (https://www.cdc.gov/niosh/data/).
3.1.2.5. Hand-searching and expert consultation. We (AM and MSP) will
hand-search for potentially eligible studies in:
• Reference lists of previous systematic reviews.• Reference lists of all study records of all included studies.• Study records published over the past 24months in the three peer-
reviewed academic journals from which we obtain the largest
number of included studies.• Study records that have cited an included study record (identified in
Web of Science citation database).• Collections of the review authors.
Additional experts will be contacted with a list of included studies
and study records, with the request to identify potentially eligible ad-
ditional ones.
3.1.3. Study selection
Study selection will be carried out with Covidence (Babineau, 2014;
Covidence, n.d.). All study records identified in the search will be
downloaded, and duplicates will be identified and deleted. Afterwards,
at least two review authors (AM and MSP) will independently screen
against eligibility criteria titles and abstracts (step 1) and then full texts
of potentially relevant records (step 2). A third review author (TL or TT)
will resolve any disagreements between the study selectors. If a study
record identified in the literature search was authored by a review
author assigned to study selection or if an assigned review author was
involved in the study, then the record will be re-assigned to another
review author for study selection. In the systematic review, we will
document the study selection in a flow chart, as per GATHER guidelines
(Stevens et al., 2016).
3.1.4. Data extraction and data items
A data extraction form will be developed and piloted until there is
convergence and agreement among data extractors. At a minimum, two
review authors (out of: AM, CP, MSP and SB) will independently extract
the data on occupational exposure to solar UVR, disaggregated by
country, sex, age and industrial sector or occupation. A third review
author (SMJ, TL or TT) will resolve conflicting extractions. At a
minimum, we will extract data on study characteristics (including study
authors, study year, study country, participants and risk factor ex-
posure), study design (including study type and measurements of the
risk factor and response rate), risk of bias (including missing data, as
indicated by response rate and other measures) and study context. The
estimates of the proportion of the population exposed to the occupa-
tional risk factor from included studies will be entered into and man-
aged with, the Review Manager, Version 5.3 (Review Manager
(RevMan), 2014) or DistillerSR (Evidence Partners, 2017) softwares.
We will also extract data on potential conflict of interest in included
studies, including the financial disclosures and funding sources of each
author and their affiliated organization. We will use a modification of a
previous method to identify and assess undisclosed financial interests
(Forsyth et al., 2014). Where no financial disclosure/conflict of interest
is provided, we will search declarations of interest both in other records
from this study published in the 36months prior to the included study
record and in other publicly available repositories (Drazen et al., 2010,
2009).
We will request missing data from the principal study author by
email or phone, using the contact details provided in the principal study
record. If no response is received, we will follow up twice via email, at
two and four weeks.
3.1.5. Risk of bias assessment
Generally agreed methods (i.e. framework plus tool) for assessing
risk of bias do not exist for systematic reviews: of input data for health
estimates (The GATHER Working Group, 2016), for burden of disease
studies, of prevalence studies in general (Munn et al., 2014) and of
prevalence studies of occupational and/or environmental risk factors
specifically (Krauth et al., 2013; Mandrioli and Silbergeld, 2015;
Vandenberg et al., 2016). None of the five standard risk of bias as-
sessment methods in systematic reviews for environmental and occu-
pational health (Rooney et al., 2016) are applicable to assessing pre-
valence studies. The Navigation Guide does not support checklist
approaches, such as (Hoy et al., 2012; Munn et al., 2014), for assessing
risk of bias in prevalence studies.
We will use a modified version of the Navigation Guide risk of bias
tool (Lam et al., 2016) that we developed specifically for Systematic
Review 1 (Appendix D). We will assess risk of bias on the levels of the
individual study and the entire body of evidence. As per our pre-
liminary tool, we will assess risk of bias along five domains: (i) selection
bias; (ii) performance bias; (iii) misclassification bias; (iv) conflict of
interest; and (v) other biases. Risk of bias will be: “low”; “probably
low”; “probably high”; “high” or “not applicable”. To judge the risk of
bias in each domain, we will apply our a priori instructions (Appendix
D).
All risk of bias assessors (AG, CA, FG, MW, SJ, SMJ, TL, AM, MSP
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and TT) will trial the tool until they synchronize their understanding
and application of each risk of bias domain, considerations and criteria
for ratings. At least two study authors (AM, MSP) will then in-
dependently judge the risk of bias for each study by outcome, and a
third author (AG, CA, FG, MW, SJ, SMJ, TL or TT) will resolve any
conflicting judgments. We will present the findings of our risk of bias
assessment for each eligible study in a standard ‘Risk of bias’ table
(Higgins and Green, 2011). Our risk of bias assessment for the entire
body of evidence will be presented in a standard ‘Risk of bias summary’
figure (Higgins and Green, 2011).
3.1.6. Synthesis of results
We will neither produce any summary measures, nor synthesise the
evidence quantitatively. The included evidence will be presented in
what could be described as an ‘evidence map’. All included data points
from included studies will be presented, together with meta-data on the
study design, number of participants, characteristics of population,
setting, and exposure measurement of the data point.
3.1.7. Quality of evidence assessment
There is no agreed method for assessing quality of evidence in
systematic reviews of the prevalence of occupational and/or environ-
mental risk factors. We will adopt or adapt the latest Navigation Guide
instructions for grading (Lam et al., 2016), including criteria (Appendix
E). We will downgrade for the following five reasons from the Grading
of Recommendations Assessment, Development and Evaluation
(GRADE) approach: (i) risk of bias; (ii) inconsistency; (iii) indirectness;
(iv) imprecision; and (v) publication bias (Schünemann et al., 2011).
We will grade the evidence, using the three Navigation Guide quality of
evidence ratings: “high”, “moderate” and “low” (Lam et al., 2016).
Within each of the relevant reasons for downgrading, we will rate any
concern per reason as “none”, “serious” or “very serious”. We will start
at “high” for non-randomized studies and will downgrade for no con-
cern by nil, for a serious concern by one grade (−1), and for a very
serious concern by two grades (−2). We will not up-grade or down-
grade the quality of evidence for the three other reasons normally
considered in GRADE assessments (i.e. large effect, dose-response and
plausible residual confounding and bias), because we consider them
irrelevant for prevalence estimates.
All quality of evidence assessors (AM, BA, MSP, RA and TL) will trial
the application of our instructions and criteria for quality of evidence
assessment until their understanding and application is synchronized.
Two separate review author groups (i.e. AM, FG, MC and TT and BA,
MSP, RA and TL, respectively) will independently judge the quality of
evidence for the entire body of evidence by outcome. A third review
author group (AG, CA, SK and SMJ) will resolve any conflicting judg-
ments. In the systematic review, for each outcome, we will present our
assessments of the risk for each GRADE domain, as well as an overall
GRADE rating.
3.1.8. Strength of evidence assessment
To our knowledge, no agreed method exists for rating strength of
evidence in systematic reviews of prevalence studies. We (AM, MSP and
SMJ) will rate the strength of the evidence for use as input data for
estimating national-level exposure to the risk factor. Our rating will be
based on a combination of the following four criteria: (i) quality of the
entire body of evidence; (ii) population coverage of evidence (WHO
regions and countries); (iii) confidence in the entire body of evidence;
and (iv) other compelling attributes of the evidence that may influence
certainty. We will rate the strength of the evidence as either “poten-
tially sufficient” or “potentially inadequate” for use as input data
(Appendix F).
3.2. Systematic Review 2
3.2.1. Eligibility criteria
3.2.1.1. Types of populations. We will include studies of working-age
(≥15 years) workers in the formal and informal economy. Studies of
children (aged< 15 years) and unpaid domestic workers will be
excluded. Participants residing in any WHO and/or ILO Member State
and any industrial setting or occupation will be included. Appendix G
provides a complete, but briefer overview of the PECO criteria.
3.2.1.2. Types of exposures. We will include studies that define solar
UVR in accordance with our standard definition (Table 1). We will
include all studies where occupational exposure to solar UVR was
measured, whether objectively (e.g. by means of dosimeters) or
subjectively, including studies that used measurements by experts
(e.g. scientists with subject matter expertise) and self-reports by the
worker or workplace administrator or manager. If a study presents both
objective and subjective measurements, then we will prioritize
objective measurements. We will include studies with measures from
any data source, including registry data.
3.2.1.3. Types of comparators. The included comparator will be
participants exposed to the theoretical minimum risk exposure level
(Table 1). We will exclude all other comparators.
3.2.1.4. Types of outcomes. We will include studies that defined
melanoma and NMSC in accordance with our standard definition of
these outcomes (Table 1).
The following measurements of melanoma and NMSC will be re-
garded as eligible:
i) Diagnosis by a physician.
ii) Hospital discharge records.
iii) Registry data of treatment for melanoma and/or NMSC.
iv) Other relevant administrative data (e.g. records of sickness absence
or disability).
v) Medically certified cause of death.
All other measure will be excluded from this systematic review.
We will include objective measures of melanoma and of NMSC in-
cluding those of only BCC or SCC (e.g., diagnosed or measured by a
dermatologist or by a trained occupational health practitioner, such as
an occupational physician or nurse, using a validated tool), as well as
subjective measures of the outcomes. If both subjective and objective
measures are presented, we will prioritize the objective measures.
3.2.1.5. Types of studies. We will include studies that investigate the
effect of occupational exposure to solar UVR on skin cancers for any
years. Eligible study designs will be randomized controlled trials
(including parallel-group, cluster, cross-over and factorial trials),
cohort studies (both prospective and retrospective), case-control
studies and other non-randomized intervention studies (including
quasi-randomized controlled trials, controlled before-after studies and
interrupted time series studies). We included a broader set of
observational study designs than is commonly included, because a
recent augmented Cochrane Review of complex interventions identified
valuable additional studies using such a broader set of study designs
(Arditi et al., 2016). As we have an interest in quantifying risk and not
in qualitative assessment of hazard (Barroga and Kojima, 2007), we will
exclude all other study designs (e.g. uncontrolled before-and-after,
cross-sectional, qualitative, modelling, case and non-original studies).
Records published in any year and any language will be included.
Again, the search will be conducted using English language terms, so
that records published in any language that present essential informa-
tion (i.e. title and abstract) in English will be included. If a record is
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written in a language other than those spoken by the authors of this
review or those of other reviews in the series (Descatha et al., 2018;
Godderis et al., 2018; Hulshof et al., 2018; Li et al., 2018; Mandrioli
et al., 2018; Rugulies et al., 2018; Teixeira et al., 2018; Tenkate et al.,
2018), then the record will be translated into English. Published and
unpublished studies will be included.
Studies conducted using unethical practices will be excluded (e.g.,
RCTs that deliberately exposed humans to a known risk factor to human
health).
3.2.1.6. Types of effect measures. We will include measures of the
relative effect of occupational exposure to solar UVR on the risk of
having, developing or dying from melanoma and NMSC, compared with
the theoretical minimum risk exposure level. In studies with low versus
high exposure, the risk estimate may be assessed based on risk
estimated in low versus high exposed workers. We will include
relative effect measures such as risk ratios and odds ratios for
mortality measures and hazard ratios for incidence measures (e.g.,
developed or died from skin cancers). Measures of absolute effects (e.g.
mean differences in risks or odds) will be converted into relative effect
measures, but if conversion is impossible, they will be excluded. To
ensure comparability of effect estimates and facilitate meta-analysis, if
a study presents an odds ratio, then we will convert it into a risk ratio, if
possible, using the guidance provided in the Cochrane Collaboration's
handbook for systematic reviews of interventions (Higgins and Green,
2011).
As shown in our logic framework (Fig. 1), we a priori consider the
following variables to be potential effect modifiers of the effect of solar
UVR on melanoma and NMSC: country, age, sex, socioeconomic posi-
tion, industrial sector, occupation and formality of economy. As med-
iating factors we consider two groups of factors that affect the exposure-
outcome relation through two different pathways, one related to work
and one to personal factors (see Fig. 1).
If a study presents estimates for the effect from two or more alter-
native models that have been adjusted for different variables, then we
will systematically prioritize the estimate from the model that we
consider best adjusted, applying the lists of confounders and mediators
identified in our logic model (Fig. 1). We will prioritize estimates from
models adjusted for more potential confounders over those from models
adjusted for fewer. For example, if a study presents estimates from a
crude, unadjusted model (Model A), a model adjusted for one potential
confounder (Model B) and a model adjusted for two potential con-
founders (Model C), then we will prioritize the estimate from Model C.
We will prioritize estimates from models unadjusted for mediators over
those from models that adjusted for mediators, because adjustment for
mediators can introduce bias. For example, if Model A has been ad-
justed for two confounders, and Model B has been adjusted for the same
two confounders and a potential mediator, then we will choose the
estimate from Model A over that from Model B. We prioritize estimates
from models that can adjust for time-varying confounders that are at
the same time also mediators, such as marginal structural models (Pega
et al., 2016), over estimates from models that can only adjust for time-
varying confounders, such as fixed-effects models (Gunasekara et al.,
2014), over estimates from models that cannot adjust for time-varying
confounding. If a study presents effect estimates from two or more
potentially eligible models, then we will explain specifically why we
prioritized the selected model.
3.2.2. Information sources and search
3.2.2.1. Electronic academic databases. At a minimum, we (AM and MP)
will search the four following electronic academic databases:
1. Ovid MEDLINE with Daily Update (1 January 1946 to 31 July
2018).
2. PubMed (1 January 1946 to 31 July 2018).
3. EMBASE (1 January 1947 to 31 July 2018).
4. Web of Science (1 January 1945 to 31 July 2018) with inclusion of
three databases: Science Citation Index Expanded; Social Sciences
Citation Index; and Arts and Humanities Citation Index.
The Ovid Medline search strategy for Systematic Review 2 is pre-
sented in Appendix H. We have tested and validated the search strategy
for the four selected databases. The International Clinical Trials
Register Platform, CISDOC and TOXNET databases were also tested, but
their scopes were found to not sufficiently cover that of the systematic
review. We will perform searches in electronic databases operated in
the English language using a search strategy in the English language.
We will adapt the search syntax to suit the other electronic academic
and grey literature databases. When we are nearing completion of the
review, we will search the PubMed database for the most recent pub-
lications (e.g., e-publications ahead of print) over the last six months.
Any deviation from the proposed search strategy in the actual search
strategy will be documented.
3.2.2.2. Electronic grey literature databases. At a minimum, we (AM and
MSP) will search the two following electronic grey literature databases:
1. OpenGrey (http://www.opengrey.eu/).
2. Grey Literature Report (http://greylit.org/).
3.2.2.3. Internet search engines. We (AM and MSP) will also search the
Google (www.google.com/) and GoogleScholar (www.google.com/
scholar/) Internet search engines and screen the first 100 hits for
potentially relevant records.
3.2.2.4. Organizational websites. The websites of the seven following
international organizations and national government departments will
be searched by AM and MSP:
1. International Labour Organization (www.ilo.org/).
2. World Health Organization (www.who.int).
3. European Agency for Safety and Health at Work (https://osha.
europa.eu/en).
4. Eurostat (www.ec.europa.eu/eurostat/web/main/home).
5. China National Knowledge Infrastructure (http://www.cnki.net/).
6. Finnish Institute of Occupational Health (https://www.ttl.fi/en/).
7. United States National Institute of Occupational Safety and Health
(NIOSH) of the United States of America, using the NIOSH data and
statistics gateway (https://www.cdc.gov/niosh/data/).
3.2.2.5. Hand-searching and expert consultation. We (AM and MSP) will
hand-search for potentially eligible studies in:
• Reference lists of previous systematic reviews.• Reference lists of all study records of all included studies.• Study records published over the past 24months in the three peer-
reviewed academic journals from which we obtain the largest
number of included studies.• Study records that have cited an included study record (identified in
Web of Science citation database).• Collections of the review authors.
Additional experts will be contacted with a list of included studies
and study records, with the request to identify potentially eligible ad-
ditional ones.
3.2.3. Study selection
Study selection will be carried out with Covidence (Babineau, 2014;
Covidence, n.d.). All study records identified in the search will be
downloaded, and duplicates will be identified and deleted. Afterwards,
at least two review authors (AM and MSP) will independently screen
against eligibility criteria titles and abstracts (step 1) and then full texts
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of potentially relevant records (step 2). A third review author (CP or
TT) will resolve any disagreements between the study selectors. If a
study record identified in the literature search was authored by a re-
view author assigned to study selection or if an assigned review author
was involved in the study, then the record will be re-assigned to another
review author for study selection. In the systematic review, we will
document the study selection in a flow chart, as per PRISMA guidelines
(Liberati et al., 2009).
3.2.4. Data extraction and data items
A data extraction form will be developed and trialled until data
extractors reach convergence and agreement. At a minimum, two re-
view authors (out of: AM, CP, MSP and SB) will extract data on study
characteristics (including study authors, study year, study country,
participants, exposure and outcome), study design (including summary
of study design, comparator, epidemiological models used and effect
estimate measure), risk of bias (including selection bias, reporting bias,
confounding, and reverse causation) and study context (e.g. data on
contemporaneous exposure to other occupational risk factors poten-
tially relevant for deaths or other health loss from skin cancers). A third
review author (SMJ, TL or TT) will resolve conflicts in data extraction.
Data will be entered into and managed with the Review Manager,
Version 5.3 (Review Manager (RevMan), 2014) or DistillerSR (Evidence
Partners, 2017) softwares, but the Health Assessment Workspace Col-
laborative (HAWC) (Shapiro, 2013) may also be used in parallel or to
prepare data for entry into RevMan 5.3.
We will also extract data on potential conflict of interest in included
studies. For each author and affiliated organization of each included
study record, we will extract their financial disclosures and funding
sources. We will use a modification of a previous method to identify and
assess undisclosed financial interest of authors (Forsyth et al., 2014).
Where no financial disclosure or conflict of interest statements are
available, we will search the name of all authors in other study records
gathered for this study and published in the prior 36months and in
other publicly available declarations of interests (Drazen et al., 2010,
2009).
We will request missing data from the principal study author by
email or phone, using the contact details provided in the principal study
record. If we do not receive a positive response from the study author,
we will send follow-up emails twice, at two and four weeks.
3.2.5. Risk of bias assessment
Standard risk of bias tools do not exist for systematic reviews for
hazard identification in occupational and environmental health, nor for
risk assessment. The five methods specifically developed for occupa-
tional and environmental health are for either or both hazard identifi-
cation and risk assessment, and they differ substantially in the types of
studies (randomized, observational and/or simulation studies) and data
(e.g. human, animal and/or in vitro) they seek to assess (Rooney et al.,
2016). However, all five methods, including the Navigation Guide (Lam
et al., 2016), assess risk of bias in human studies similarly (Rooney
et al., 2016).
The Navigation Guide was specifically developed to translate the
rigor and transparency of systematic review methods applied in the
clinical sciences to the evidence stream and decision context of en-
vironmental health (Woodruff and Sutton, 2014), which includes
workplace environment exposures and associated health outcomes. The
guide is our overall organizing framework, and we will also apply its
risk of bias assessment method in Systematic Review 2. The Navigation
Guide risk of bias assessment method builds on the standard risk of bias
assessment methods of the Cochrane Collaboration (Higgins and Green,
2011) and the US Agency for Healthcare Research and Quality
(Viswanathan et al., 2008). Some further refinements of the Navigation
Guide method may be warranted (Goodman et al., 2017), but it has
been successfully applied in several completed and ongoing systematic
reviews (Johnson et al., 2016, 2014; Koustas et al., 2014; Lam et al.,
2017, 2015, 2014; Rooney et al., 2016; Vesterinen et al., 2015). In our
application of the Navigation Guide method, we will draw heavily on
one of its latest versions, as presented in the protocol for an ongoing
systematic review (Lam et al., 2016). Should a more suitable method
become available, we may switch to it.
We will assess risk of bias on the individual study level and on the
body of evidence overall. The nine risk of bias domains included in the
Navigation Guide method for human studies are: (i) source population
representation; (ii) blinding; (iii) exposure assessment; (iv) outcome
assessment; (v) confounding; (vi) incomplete outcome data; (vii) se-
lective outcome reporting; (viii) conflict of interest; and (ix) other
sources of bias. While two of the earlier case studies of the Navigation
Guide did not utilize outcome assessment as a risk of bias domain for
studies of human data (Johnson et al., 2014; Koustas et al., 2014; Lam
et al., 2014; Vesterinen et al., 2015), all of the subsequent reviews have
included this domain (Johnson et al., 2016; Lam et al., 2017, 2016,
2015, 2014). Risk of bias or confounding ratings will be: “low”;
“probably low”; “probably high”; “high” or “not applicable” (Lam et al.,
2016). To judge the risk of bias in each domain, we will apply a priori
instructions (Appendix I), which we have adopted or adapted from an
ongoing Navigation Guide systematic review (Lam et al., 2016). For
example, a study will be assessed as carrying “low” risk of bias from
source population representation, if we judge the source population to
be described in sufficient detail (including eligibility criteria, recruit-
ment, enrollment, participation and loss to follow up) and the dis-
tribution and characteristics of the study sample to indicate minimal or
no risk of selection effects. The risk of bias at study level will be de-
termined by the worst rating in any bias domain for any outcome. For
example, if a study is rated as “probably high” risk of bias in one do-
main for one outcome and “low” risk of bias in all other domains for the
outcome and in all domains for all other outcomes, the study will be
rated as having a “probably high” risk of bias overall.
All risk of bias assessors (BA, RA, MC, AG, FG, SMJ, SK, TL, AM,
MSP and TT) will jointly trial the application of the risk of bias criteria
until they have synchronized their understanding and application of
these criteria. At least two study authors (out of: BA, RA, MC, FG, TL,
AM, MSP and TT) will independently judge the risk of bias for each
study by outcome. Where individual assessments differ, a third author
(AG, SK and SMJ) will resolve the conflict. In the systematic review, for
each included study, we will report our study-level risk of bias assess-
ment by domain in a standard ‘Risk of bias’ table (Higgins and Green,
2011). For the entire body of evidence, we will present the study-level
risk of bias assessments in a ‘Risk of bias summary’ figure (Higgins and
Green, 2011).
3.2.6. Synthesis of results
We will conduct meta-analyses separately for estimates of the effect
on prevalence, incidence and mortality. If we find two or more studies
with an eligible effect estimate, two or more review authors (out of: BA,
RA, TL, and MSP) will independently investigate the clinical hetero-
geneity of the studies in terms of types of studies, participants (in-
cluding country, sex, age and industrial sector or occupation), level of
risk factor exposure, comparator and outcomes. If we find that effect
estimates differ considerably by country, sex and/or age, or a combi-
nation of these, then we will synthesise evidence for the relevant po-
pulations defined by country, sex and/or age, or combination thereof.
Differences by country could include or be expanded to include dif-
ferences by country group (e.g. WHO region or World Bank income
group). If we find that effect estimates are clinically homogenous across
countries, sexes and age groups, then we will combine studies from all
of these populations into one pooled effect estimate that could be ap-
plied across all combinations of countries, sexes and age groups in the
WHO/ILO joint methodology.
If we judge two or more studies for the relevant combination of
country, sex and age group, or combination thereof, to be sufficiently
clinically homogenous to potentially be combined quantitatively using
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quantitative meta-analysis, then we will test the statistical hetero-
geneity of the studies using the I2 statistic (Figueroa, 2014). If two or
more clinically homogenous studies are found to be sufficiently
homogenous statistically to be combined in a meta-analysis, we will
pool the risk ratios of the studies in a quantitative meta-analysis, using
the inverse variance method with a random effects model to account for
cross-study heterogeneity (Figueroa, 2014). The meta-analysis will be
conducted in RevMan 5.3, but the data for entry into these programmes
may be prepared using another recognized statistical analysis pro-
gramme, such as Stata. We will quantitatively combine neither data
from studies with different designs (e.g. combining cohort studies with
case-controls studies), nor unadjusted and adjusted models. We will
only combine studies that we judge to have a minimum acceptable level
of adjustment for confounders. If quantitative synthesis is not feasible,
then we will synthesise the study findings narratively and identify the
estimates that we judged to be the highest quality evidence available.
3.2.7. Additional analyses
If we source micro-data on exposure, outcome and potential con-
founding variables, we may conduct meta-regressions to adjust opti-
mally for potential confounders.
If there is evidence for differences in effect estimates by country,
sex, age, industrial sector and/or occupation, or by a combination of
these variables, then we will conduct subgroup analyses by the relevant
variable or combination of variables, as feasible. Where both studies on
workers in the informal economy and in the formal economy are in-
cluded, then we will conduct sub-group analyses by formality of
economy. Findings of these subgroup analyses, if any, will be used as
parameters for estimating burden of disease specifically for relevant
populations defined by these variables. Where possible, we will also
conduct subgroup analyses by study design (e.g. randomized controlled
trials versus cohort studies versus case-control studies) and temporal
direction for case-control and cohort studies (i.e. retrospective versus
prospective). Subgroup analyses may also be conducted by different
levels of solar UV exposure (e.g. quartiles of exposure and lifetime ex-
posure in years) and specific types of melanoma and NMSC.
We will perform a sensitivity analyses that will include only studies
judged to be of “low” or “probably low” risk of bias from conflict of
interest; judged to be of “low” or “probably low” risk of bias; and with
documented or approximated ICD-10 diagnostic codes. For meta-ana-
lyses with I2≥ 75%, we may also conduct sensitivity analyses using
two alternative meta-analytic models, namely the inverse variance
heterogeneity (IVhet) (Doi et al., 2015a) and quality effects (QE) (Doi
et al., 2015b) models.
3.2.8. Quality of evidence assessment
We will assess quality of evidence using a modified version of the
Navigation Guide (Woodruff and Sutton, 2014) quality of evidence as-
sessment tool (Lam et al., 2016). The tool is based on the GRADE ap-
proach (Schünemann et al., 2011) adapted specifically to systematic re-
views in occupational and environmental health (Morgan et al., 2016).
Should a more suitable method become available, we may switch to it.
We will assess quality of evidence for the entire body of evidence by
outcome, with any disagreements resolved by a third review author. We
will adopt or adapt the latest Navigation Guide instructions (Appendix E)
for grading the quality of evidence (Lam et al., 2016). We will down-
grade the quality of evidence for the following five GRADE reasons: (i)
risk of bias; (ii) inconsistency; (iii) indirectness; (iv) imprecision; and
(v) publication bias. If our systematic review includes ten or more
studies, we will generate a funnel plot to judge concerns on publication
bias. If it includes nine or fewer studies, we will judge the risk of
publication bias qualitatively. To assess risk of bias from selective re-
porting, protocols of included studies, if any, will be screened to
identify instances of selective reporting.
We will grade the evidence, using the three Navigation Guide stan-
dard quality of evidence ratings: “high”, “moderate” and “low” (Lam
et al., 2016). Within each of the relevant domains, we will rate the
concern for the quality of evidence, using the ratings “none”, “serious”
and “very serious”. As per Navigation Guide, we will start at “high” for
randomized studies and “moderate” for observational studies. Quality
will be downgrade for no concern by nil grades (0), for a serious con-
cern by one grade (−1) and for a very serious concern by two grades
(−2). We will up-grade the quality of evidence for the following other
reasons: large effect, dose-response and plausible residual confounding
and bias. For example, if we have a serious concern for risk of bias in a
body of evidence consisting of observational studies (−1), but no other
concerns, and there are no reasons for upgrading, then we will down-
grade its quality of evidence by one grade from “moderate” to “low”.
3.2.9. Strength of evidence assessment
We will apply the standard Navigation Guide methodology (Lam
et al., 2016) to rate the strength of the evidence. The rating will be
based on a combination of four criteria: (i) quality of the body of evi-
dence; (ii) direction of effect; (iii) confidence in effect; and (iv) other
compelling attributes of the data that may influence our certainty. The
ratings for strength of evidence for the effect of solar UV exposure on
melanoma and NMSC will be “sufficient evidence of toxicity/harmful-
ness”, “limited of toxicity/harmfulness”, “inadequate of toxicity/
harmfulness” and “evidence of lack of toxicity/harmfulness” (Appendix
J).
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